JSJCX | NRGEX | JSJCX / NRGEX | |
Total Expense Ratio | 1.95 | 0.03 | 6,500% |
Annual Report Gross Expense Ratio | 2.10 | 0.69 | 304% |
Fund Existence | 7 years | 4 years | - |
Gain YTD | -1.552 | -2.228 | 70% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 234M | 9.27B | 3% |
Annual Yield % from dividends | 2.57 | 0.55 | 471% |
Returns for 1 year | -0.90 | -4.64 | 19% |
Returns for 3 years | 20.92 | 11.41 | 183% |
Returns for 5 years | -14.15 | N/A | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
RAYD | 36.12 | 0.21 | +0.58% |
Rayliant Quantitative Dev Mkt Eq ETF | |||
PEJ | 57.77 | N/A | N/A |
Invesco Dynamic Leisure and Entmnt ETF | |||
BBC | 21.59 | N/A | N/A |
Virtus LifeSci Biotech Clinical Trls ETF | |||
OUNZ | 32.17 | -0.08 | -0.25% |
VanEck Merk Gold Trust | |||
FIXP | 19.73 | -0.05 | -0.25% |
FolioBeyond Enhanced Fixed Inc Prm ETF |